Evidence map›Paper›PMID 25358954›Full record

ReviewJournal of biomedical science2014

Hyaluronan and cardiac regeneration.

Francesca Bonafè, Marco Govoni, Emanuele Giordano, Claudio Marcello Caldarera, Carlo Guarnieri, Claudio Muscari

Open access · diamondAbstract readReview
In one paragraph

Review in Journal of biomedical science, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Hyaluronic Acid-Based Bioink for Anisotropic Neural Tissue Cryobioprinting.International journal of extreme manufacturing · 2026
    Article
  3. Review
  4. Advances in the Targeted Drug Delivery System for Renal Fibrosis.International journal of nanomedicine · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Circulation · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Francesca BonafèDepartment of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Via Irnerio, 48, Bologna, 40126, Italy. f.bonafe@unibo.it.
Marco GovoniBioEngLab, Health Science and Technology, Interdepartmental Center for Industrial Research (HST-CIRI), University of Bologna, Ozzano Emilia, Italy. marco.govoni6@unibo.it.
Emanuele GiordanoBioEngLab, Health Science and Technology, Interdepartmental Center for Industrial Research (HST-CIRI), University of Bologna, Ozzano Emilia, Italy. emanuele.giordano@unibo.it.
Claudio Marcello CaldareraDepartment of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Via Irnerio, 48, Bologna, 40126, Italy. claudio.caldarera@unibo.it.
Carlo GuarnieriDepartment of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Via Irnerio, 48, Bologna, 40126, Italy. carlo.guarnieri@unibo.it.
Claudio MuscariDepartment of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Via Irnerio, 48, Bologna, 40126, Italy. claudio.muscari@unibo.it.
Centre International de Recherche en Infectiologie · FRUniversity of Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyaluronan (HA) is abundantly expressed in several human tissues and a variety of roles for HA has been highlighted. Particularly relevant for tissue repair, HA is actively produced during tissue injury, as widely evidenced in wound healing investigations. In the heart HA is involved in physiological functions, such as cardiac development during embryogenesis, and in pathological conditions including atherosclerosis and myocardial infarction. Moreover, owing to its relevant biological properties, HA has been widely used as a biomaterial for heart regeneration after a myocardial infarction. Indeed, HA and its derivatives are biodegradable and biocompatible, promote faster healing of injured tissues, and support cells in relevant processes including survival, proliferation, and differentiation. Injectable HA-based therapies for cardiovascular disease are gaining growing attention because of the benefits obtained in preclinical models of myocardial infarction. HA-based hydrogels, especially as a vehicle for stem cells, have been demonstrated to improve the process of cardiac repair by stimulating angiogenesis, reducing inflammation, and supporting local and grafted cells in their reparative functions. Solid-state HA-based scaffolds have been also investigated to produce constructs hosting mesenchymal stem cells or endothelial progenitor cells to be transplanted onto the infarcted surface of the heart. Finally, applying an ex-vivo mechanical stretching, stem cells grown in HA-based 3D scaffolds can further increase extracellular matrix production and proneness to differentiate into muscle phenotypes, thus suggesting a potential strategy to create a suitable engineered myocardial tissue for cardiac regeneration.

Indexed as

RegenerationAngiogenesis Inducing AgentsBiocompatible MaterialsHeartHumansHyaluronic AcidMesenchymal Stem CellsMyocardial InfarctionWound HealingAngiogenesis Inducing AgentsBiocompatible MaterialsHyaluronic Acid

Identifiers

PMID25358954
PMCPMC4226915
OpenAlexW2152890847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.